Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Vink

Showing results (121-130 of 203) with videos related to

Pageof 21
Sort By:
Physical Review Letters|October 10, 2006
Isotropic-nematic interface and wetting in suspensions of colloidal plateletsD van der Beek, H Reich, P van der Schoot, et al.
European Geriatric Medicine|May 3, 2023
Correction: Health-related quality-of-life trajectories during/after surgery and adjuvant chemotherapy in patients with colon cancerE R M Scheepers, G R Vink, A H W Schiphorst, et al.
European Journal of Cancer Care|September 3, 2022
The impact of surgery and adjuvant chemotherapy on health-related quality of life in patients with colon cancer: Changes at group level versus individual levelEllen R M Scheepers, Geraldine R Vink, Anandi H W Schiphorst, et al.
Therapeutic Advances in Gastroenterology|March 31, 2021
Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patientsGabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
Therapeutic Advances in Gastroenterology|September 30, 2020
Model-based evaluation of the cost effectiveness of 3 <i>versus</i> 6 months' adjuvant chemotherapy in high-risk stage II colon cancer patientsGabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
International Journal of Cancer|July 9, 2020
Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real-life dataPatricia A H Hamers, Marloes A G Elferink, Rebecca K Stellato, et al.
European Geriatric Medicine|March 25, 2023
Health-related quality-of-life trajectories during/after surgery and adjuvant chemotherapy in patients with colon cancerE R M Scheepers, G R Vink, A H W Schiphorst, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2023
Impact of colorectal cancer screening on survival after metachronous metastasisPatricia A H Hamers, Geraldine R Vink, Marloes A G Elferink, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort studyK N Gaarenstroom, B van der Hiel, R A E M Tollenaar, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2024
Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 monthsIngrid A Franken, Frederieke H van der Baan, Geraldine R Vink, et al.
Pageof 21

Showing results (121-130 of 203) with videos related to

Sort By:
Pageof 21
Physical Review Letters|October 10, 2006
Isotropic-nematic interface and wetting in suspensions of colloidal plateletsD van der Beek, H Reich, P van der Schoot, et al.
European Geriatric Medicine|May 3, 2023
Correction: Health-related quality-of-life trajectories during/after surgery and adjuvant chemotherapy in patients with colon cancerE R M Scheepers, G R Vink, A H W Schiphorst, et al.
European Journal of Cancer Care|September 3, 2022
The impact of surgery and adjuvant chemotherapy on health-related quality of life in patients with colon cancer: Changes at group level versus individual levelEllen R M Scheepers, Geraldine R Vink, Anandi H W Schiphorst, et al.
Therapeutic Advances in Gastroenterology|March 31, 2021
Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patientsGabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
Therapeutic Advances in Gastroenterology|September 30, 2020
Model-based evaluation of the cost effectiveness of 3 <i>versus</i> 6 months' adjuvant chemotherapy in high-risk stage II colon cancer patientsGabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
International Journal of Cancer|July 9, 2020
Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real-life dataPatricia A H Hamers, Marloes A G Elferink, Rebecca K Stellato, et al.
European Geriatric Medicine|March 25, 2023
Health-related quality-of-life trajectories during/after surgery and adjuvant chemotherapy in patients with colon cancerE R M Scheepers, G R Vink, A H W Schiphorst, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2023
Impact of colorectal cancer screening on survival after metachronous metastasisPatricia A H Hamers, Geraldine R Vink, Marloes A G Elferink, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort studyK N Gaarenstroom, B van der Hiel, R A E M Tollenaar, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2024
Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 monthsIngrid A Franken, Frederieke H van der Baan, Geraldine R Vink, et al.
Pageof 21